Gut microbiome dysbiosis as a potential biomarker for liver metabolic disorders in in neonatal hemolytic jaundice
Enterobacter is linked to multiple metabolic pathways in the liver via the secretion of numerous enzymes along the gut-liver axis metabolic pathway. This interaction indirectly reflects the metabolic status and disease progression in neonatal hemolytic jaundice. Consequently, Enterobacter may serve as a potential diagnostic marker of the gut microbiota for assessing liver metabolic disorders associated with hemolytic jaundice.
Authors
- Feng Zhu (ORCID: https://orcid.org/0000-0002-9356-2154)
- Jingling Zhang (ORCID: https://orcid.org/0000-0002-3427-8671)
- Bi‐Cheng Zhou (ORCID: https://orcid.org/0000-0003-1560-4950)
- Lili Wang (ORCID: https://orcid.org/0000-0001-7456-1001)
- Jin Huang (ORCID: https://orcid.org/0000-0001-7160-2314)
- Ying Li (ORCID: https://orcid.org/0000-0001-9560-2212)
- Rui Zhang (ORCID: https://orcid.org/0000-0002-6371-9050)
- Yingying Li
Institutions
- Anhui Medical University (CN)
- Suzhou Municipal Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1186/s12887-025-05692-8
- Primary Topic
- Neonatal Health and Biochemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.00